(19)
(11) EP 2 029 146 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
21.02.2018 Bulletin 2018/08

(45) Mention of the grant of the patent:
20.12.2017 Bulletin 2017/51

(21) Application number: 07798313.8

(22) Date of filing: 08.06.2007
(51) International Patent Classification (IPC): 
A61K 31/567(2006.01)
A61K 9/00(2006.01)
 A61K 31/565(2006.01)
(86) International application number:
PCT/US2007/070761
(87) International publication number:
WO 2007/146805 (21.12.2007 Gazette 2007/51)

(54)

METHODS TO ADMINISTER SOLID DOSAGE FORMS OF ETHINYL ESTRADIOL AND PRODRUGS THEREOF WITH IMPROVED BIOAVAILABILTY

VERFAHREN ZUR VERABREICHUNG FESTER DOSIERUNGSFORMEN VON ETHINYL-ESTRADIOL UND PRODRUGS DAVON MIT VERBESSERTER BIOVERFÜGBARKEIT

PROCÉDÉS DESTINÉS À L'ADMINISTRATION DE FORMES POSOLOGIQUES SOLIDES D'ÉTHINYL ESTRADIOL ET DE SES PROMÉDICAMENTS PRÉSENTANT UNE BIODISPONIBILITÉ AMÉLIORÉE

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

(30) Priority: 08.06.2006 US 812016 P

(43) Date of publication of application:
04.03.2009 Bulletin 2009/10

(73) Proprietor: Allergan Pharmaceuticals International Limited
Dublin 17 (IE)

(72) Inventors:
  • deVRIES, Tina
    Long Valley, NJ 07853 (US)
  • McNAMEE, Brian
    Belfast, County Antrim N. Ireland BT8 6WD (GB)

(74) Representative: FRKelly 
27 Clyde Road
Dublin D04 F838
Dublin D04 F838 (IE)


(56) References cited: : 
EP-A- 0 286 581
US-A- 5 047 244
US-B1- 6 667 050
 US-A- 4 764 378
US-B1- 6 241 529
   
  • ANONYMOUS: "Ovcon 35 Chewable" INTERNET ARTICLE, 15 September 2005 (2005-09-15), pages 1-3, XP002459477 Retrieved from the Internet: URL:HTTP://WWW.DRUGDIGEST.ORG>
  • "Mannitol ED - Ammon H", HUNNIUS PHARMAZEUTISCHES WÖRTERBUCH, WALTER DE GRUYTER, DE, 1 January 2004 (2004-01-01), pages 1-2, XP007917997,
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).